Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients with a PD-L1 Positive Status: A Case Report.

Curr Issues Mol Biol · 2023 · PMC10529065 · PMID 37754265

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Therefore, the combination of autophagy activation and a lack of antitumor immunity may be significant molecular features in PD-L1-positive gastric cancers.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.